Crestone Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Crestone Asset Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,226	Closed	-$357K	–	82
2021 Q1	$357K	Sell	2,226 -622	-22%	-$106K	0.09%	52
2020 Q4	$478K	Sell	2,848 -3,429	-55%	-$556K	0.13%	44
2020 Q3	$987K	Sell	6,277 -3,045	-33%	-$498K	0.31%	33
2020 Q2	$1.56M	Sell	9,322 -7,801	-46%	-$1.22M	0.52%	29
2020 Q1	$2.25M	Buy	17,123 +29	+0.2%	+$4.13K	0.91%	21
2019 Q4	$2.54M	Sell	17,094 -1,215	-7%	-$167K	0.86%	25
2019 Q3	$2.27M	Sell	18,309 -4,033	-18%	-$537K	0.86%	24
2019 Q2	$3.15M	Buy	22,342 +1,203	+6%	+$166K	1.1%	24
2019 Q1	$3.19M	Sell	21,139 -1,345	-6%	-$194K	1.13%	24
2018 Q4	$2.79M	Buy	+22,484	New	+$3.07M	1.05%	23

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Crestone Asset Management's FBT Position: Q2 2021 in Review

Crestone Asset Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2021, closing a stake of 2,226 shares — an estimated $357K sold.

Crestone Asset Management first reported a position in FBT in Q4 2018 and held it in 10 quarters. The position peaked at $3.19M in Q1 2019. 233 funds tracked by Wall St. Rank hold FBT as of Q2 2021.

Crestone Asset Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2021 after selling out during the quarter.
Crestone Asset Management sold 2,226 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2021, an estimated $357K.
Crestone Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2018 and held it in 10 quarters.
Crestone Asset Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.19M in Q1 2019.
233 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2021.

Based on Crestone Asset Management's 13F filing for Q2 2021, filed 2 Aug 2021.